MXPA06000539A - Derivado novedoso de heteroarilo. - Google Patents

Derivado novedoso de heteroarilo.

Info

Publication number
MXPA06000539A
MXPA06000539A MXPA06000539A MXPA06000539A MXPA06000539A MX PA06000539 A MXPA06000539 A MX PA06000539A MX PA06000539 A MXPA06000539 A MX PA06000539A MX PA06000539 A MXPA06000539 A MX PA06000539A MX PA06000539 A MXPA06000539 A MX PA06000539A
Authority
MX
Mexico
Prior art keywords
substituted
heteroaryl
heteroaryl derivative
novel heteroaryl
formula
Prior art date
Application number
MXPA06000539A
Other languages
English (en)
Spanish (es)
Inventor
Ryu Nagata
Original Assignee
Dainippon Sumitomo Pharma Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dainippon Sumitomo Pharma Co filed Critical Dainippon Sumitomo Pharma Co
Publication of MXPA06000539A publication Critical patent/MXPA06000539A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D207/32—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D207/33—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms with substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D207/333—Radicals substituted by oxygen or sulfur atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/64—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/06—Benzimidazoles; Hydrogenated benzimidazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
    • C07D235/12—Radicals substituted by oxygen atoms

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Pyrrole Compounds (AREA)
MXPA06000539A 2003-07-15 2004-07-13 Derivado novedoso de heteroarilo. MXPA06000539A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2003274684 2003-07-15
PCT/JP2004/010282 WO2005012245A1 (ja) 2003-07-15 2004-07-13 新規ヘテロアリール誘導体

Publications (1)

Publication Number Publication Date
MXPA06000539A true MXPA06000539A (es) 2006-03-30

Family

ID=34113749

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA06000539A MXPA06000539A (es) 2003-07-15 2004-07-13 Derivado novedoso de heteroarilo.

Country Status (11)

Country Link
US (2) US7425642B2 (enExample)
EP (1) EP1647546B1 (enExample)
JP (2) JP4820169B2 (enExample)
KR (1) KR101086654B1 (enExample)
CN (1) CN100516041C (enExample)
AT (1) ATE556051T1 (enExample)
CA (1) CA2531064C (enExample)
ES (1) ES2383895T3 (enExample)
MX (1) MXPA06000539A (enExample)
TW (1) TW200523249A (enExample)
WO (1) WO2005012245A1 (enExample)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPWO2006075638A1 (ja) * 2005-01-14 2008-06-12 大日本住友製薬株式会社 新規ヘテロアリール誘導体
US20060241073A1 (en) * 2005-04-20 2006-10-26 Wanders Ronaldus J A Means and methods for counteracting fatty acid accumulation
ATE532770T1 (de) 2006-09-05 2011-11-15 Kyowa Hakko Kirin Co Ltd Imidazolderivat
WO2008157537A2 (en) * 2007-06-19 2008-12-24 Ironwood Pharmaceuticals, Inc Compositions and methods of use for treating or preventing lipid related disorders
CN102202662A (zh) * 2008-10-31 2011-09-28 大日本住友制药株式会社 抗糖尿病剂
JPWO2010110440A1 (ja) 2009-03-26 2012-10-04 大日本住友製薬株式会社 新規認知機能障害治療剤
TW201105337A (en) * 2009-07-01 2011-02-16 Dainippon Sumitomo Pharma Co Medicine derived from a combination of SGLT1-inhibitor and insulin sensitizer
CA2787785C (en) 2010-01-28 2018-03-06 President And Fellows Of Harvard College Compositions and methods for enhancing proteasome activity
WO2012007500A2 (de) 2010-07-15 2012-01-19 Bayer Cropscience Ag Neue heterocyclische verbindungen als schädlingsbekämpfungsmittel
WO2012154967A1 (en) 2011-05-12 2012-11-15 Proteostasis Therapeutics, Inc. Proteostasis regulators
WO2013138600A1 (en) * 2012-03-16 2013-09-19 Rosen Eliot M Radioprotector compounds
US9849135B2 (en) 2013-01-25 2017-12-26 President And Fellows Of Harvard College USP14 inhibitors for treating or preventing viral infections
WO2015073528A1 (en) 2013-11-12 2015-05-21 Proteostasis Therapeutics, Inc. Proteasome activity enhancing compounds

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2752361A1 (de) * 1977-11-24 1979-06-07 Troponwerke Gmbh & Co Kg Neue indolderivate, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
WO1998040385A1 (en) * 1997-03-07 1998-09-17 Novo Nordisk A/S 4,5,6,7-TETRAHYDRO-THIENO[3,2-c]PYRIDINE DERIVATIVES, THEIR PREPARATION AND USE
US6177443B1 (en) 1997-03-07 2001-01-23 Novo Nordisk A/S 4,5,6,7-tetrahydro-thieno[3, 2-C]pyridine derivatives, their preparation and use
AU2001258784A1 (en) 2000-05-22 2001-12-03 Takeda Chemical Industries Ltd. Tyrosine phosphatase inhibitors
JP2002121186A (ja) * 2000-05-22 2002-04-23 Takeda Chem Ind Ltd チロシンホスファターゼ阻害剤
SK17342002A3 (sk) * 2000-06-26 2004-06-08 Pfizer Products Inc. Derivát pyrolo[2,3-d]pyrimidínu ako činidlo potlačujúce imunitu
WO2002085851A1 (en) * 2001-04-19 2002-10-31 Sumitomo Pharmaceuticals Company, Limited Pyrrole derivative
JP2003171275A (ja) 2001-12-11 2003-06-17 Sumitomo Pharmaceut Co Ltd ＰＰＡＲδアゴニスト
AU2003284479A1 (en) * 2002-11-28 2004-06-18 Sumitomo Pharmaceuticals Co., Ltd. Novel heteroaryl derivative

Also Published As

Publication number Publication date
US20060194857A1 (en) 2006-08-31
JP4820169B2 (ja) 2011-11-24
EP1647546B1 (en) 2012-05-02
EP1647546A4 (en) 2008-07-23
KR20060040681A (ko) 2006-05-10
CN1849303A (zh) 2006-10-18
ES2383895T3 (es) 2012-06-27
CA2531064C (en) 2012-05-22
JP2011251974A (ja) 2011-12-15
ATE556051T1 (de) 2012-05-15
JPWO2005012245A1 (ja) 2006-09-14
US20080306275A1 (en) 2008-12-11
KR101086654B1 (ko) 2011-11-24
EP1647546A1 (en) 2006-04-19
CA2531064A1 (en) 2005-02-10
TW200523249A (en) 2005-07-16
WO2005012245A1 (ja) 2005-02-10
CN100516041C (zh) 2009-07-22
US7425642B2 (en) 2008-09-16
HK1087409A1 (en) 2006-10-13
TWI331142B (enExample) 2010-10-01

Similar Documents

Publication Publication Date Title
EP1674452A4 (en) NOVEL 4-PHENYLAMINO-BENZALDOXIME DERIVATIVE AND ITS USE AS MEK INHIBITOR
MXPA06000539A (es) Derivado novedoso de heteroarilo.
GEP20094676B (en) Piperidine compounds and pharmaceutical compositions containing them
ITRM20010464A1 (it) Derivati retinoidi ad attivita' antiangiogenica, antitumorale e pro-apoptotica.
IN2014DN02278A (enExample)
MY132698A (en) Herbicidal composition
WO2004018449A8 (en) Piperidine-derivatives as pde4 inhibitors
DE60325234D1 (de) Biaryldiazabicycloalkanamide als nicotinische acetylcholinagonisten
DE60228071D1 (de) Spiropyrazol-verbindungen
ECSP066753A (es) Antagonistas del receptor de quimiocina
DE602004009200D1 (de) Tetrahydrochinazolinderivate als cfr-antagonisten
MXPA03011050A (es) Conjugados de lipido-polimero.
DE60027144D1 (de) Hydroxamsäure-derivate
MY138826A (en) 2,7-substituted indoles
JO2413B1 (en) Benzoxazine derivatives and their use
TR200100961T2 (tr) İzosorbid mononitrat türevleri ve bunların azaltılmış toleranslı damar genişletici olarak kullanılması
GB0712499D0 (en) Rigid amines
MXPA05005198A (es) Derivados de imidazoquinolina, como ligandos del receptor a3 de adenosina.
WO2007056091A3 (en) 2-phenyl-2h-pyraz0le derivatives as p2x7 receptor antagonists and uses thereof
WO2004000793A3 (en) Aminoacetonitrile derivatives suitable for controlling parasites
DE60333578D1 (de) Lamellarinanaloga mit antitumorwirkung
EP1837329A4 (en) NEW HETEROARYL DERIVATIVE
EP1221445A4 (en) PENTACYCLIC TAXAN COMPOUNDS
WO2004106431A3 (en) Curable polymer compound
DK1255745T3 (da) Syntese af vandoplöseligt 9-dihydro-paclitaxel afledninger fra 9-dihydro-13-acetylbaccatin III

Legal Events

Date Code Title Description
FG Grant or registration